Vascular, pulmonary and cardiac involvement in Behcet’s disease

F. Kanat, M. Alpaslan, E. Kurt, O. Imecik (Konya, Turkey)

Source: Annual Congress 2004 - Heart and lung
Session: Heart and lung
Session type: Thematic Poster Session
Number: 1819
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Kanat, M. Alpaslan, E. Kurt, O. Imecik (Konya, Turkey). Vascular, pulmonary and cardiac involvement in Behcet’s disease. Eur Respir J 2004; 24: Suppl. 48, 1819

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary vascular disease
Source: HERMES Summer School 2014 - Educational material
Year: 2014

Pulmonary complications of Behcet disease
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007


Vascular dysfunction in patients with pulmonary sarcoidosis
Source: Annual Congress 2007 - Sarcoidosis: various aspects
Year: 2007


Pulmonary involvement in behcet's disease
Source: Eur Respir J 2002; 20: Suppl. 38, 63s
Year: 2002

Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease
Source: Eur Respir J 2005; 26: 969-972
Year: 2005



Pulmonary hypertension associated with sarcoidosis
Source: Eur Respir Mon 2012; 57: 166-181
Year: 2012


Pulmonary hypertension and pulmonary vascular disease: course report
Source: Breathe, 14 (1) e4; 10.1183/20734735.019917
Year: 2018



Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Pulmonary vascular and cardiac impairment in interstitial lung disease
Source: Eur Respir Rev 2017; 26: 160128
Year: 2017



Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
Source: Eur Respir J 2009; 33: 371-379
Year: 2009



Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 177-180
Year: 2009



Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
Source: Eur Respir J 2014; 44: 1275-1288
Year: 2014



A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


Pulmonary artery dilation and increased lung density in systemic sclerosis
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015


Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013